You are here: Industry Insights > drug

News List

NICE recommends Janssen's first-of-its-kind Crohn's drug Stelara pharmafile
May 04, 2017
Janssen has announced that it has secured recommendation from NICE for Stelara (ustekinumab) in the...
Aeterna Zentaris’ endometrial cancer drug fails in Phase III pharmatimes
May 04, 2017
A late stage clinical study of Aeterna Zentaris’ Zoptrex in women with locally advanced, recurrent or metastatic...
NICE nod for Amgen’s rare leukaemia drug pharmatimes
May 04, 2017
Patients with a rare form of leukaemia look set to win routine access to a novel treatment option on the NHS in England...
Cancer Drugs Fund poor value for money, study finds pharmatimes
May 02, 2017
England’s Cancer Drugs Fund is poor value for money and may be exposing patients to unnecessary harm, concludes ...
NICE green light for Lilly’s psoriasis drug pharmatimes
April 27, 2017
Patients with plaque psoriasis should be able to get routine access to Eli Lilly’s Taltz on the NHS within the next three months if they meet certain eligibility criteria.
HitGen and Pfizer partner to build and screen new DNA-Encoded Libraries pharmaceutical-technology
April 21, 2017
HitGen and Pfizer have entered a multi-year research collaboration and licence agreement to build and screen novel DNA-encoded libraries (DELs) to help discover unique small-molecule leads for use in drug development.
‘World Hemophilia Day’ marked by release of data pharmafile
April 21, 2017
‘World Hemophilia Day’ occurred on 17 April and the day was marked by the release of data from two companies...
New drug study successfully halts neurodegeneration in mice pharmafile
April 21, 2017
A team of scientists at Medical Research Council’s (MRC) Toxicology Unit in Leicester, UK have identified ...
AbbVie’s experimental cancer drug hits wall in clinical study pharmafile
April 21, 2017
AbbVie have released that two Phase 3 trials of its experimental cancer drug, veliparib, missed both of their primary...
US FDA declines approval of Eli Lilly and Incyte’s baricitinib drug to treat RA pharmaceutical-technology
April 19, 2017
Eli Lilly and partner Incyte have announced that the US Food and Drug Administration (FDA) has declined to approve a ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page